{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:38:28Z","timestamp":1783035508966,"version":"3.54.6"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asthma exhibits heterogeneity, including type 2 (T2-high) and non-T2 phenotypes. This study aimed to elucidate the inflammatory mechanisms that drive non-type 2 asthma, a subtype characterized by low immunoglobulin E levels and negative allergic sensitization. This context considers the complex processes of allergic sensitization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed gene expression analysis in non-T2 (n = 11) versus T2-high (n = 17) pediatric patients using public datasets GSE145505 for comparison (non-atopic and high-atopic datasets). We applied Ingenuity Pathway Analysis (IPA) to identify canonical pathways. We used the Database for Annotation, Visualization, and Integrated Discovery (DAVID) for functional annotation. We examined the Reactome pathway activities, focusing on differential genes related to high-affinity immunoglobulin E receptor (Fc\u03f5RI) signaling and B-cell receptor (BCR) signaling. We conducted Weighted Gene Co-expression Network Analysis (WGCNA) for a specific gene module. We also quantified the spontaneous secretion of 12 serum cytokines in an independent pediatric (non-T2, n = 50; T2-high, n = 142) and adult (non-T2, n = 111; T2-high, n = 103) asthma cohort, and we performed logistic regression to assess their associations with non-T2 asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IPA Core Analysis predicted the inhibition of key canonical pathways in non-type 2 asthma, notably including Fc\u03f5RI signaling and BCR signaling, with the associated downregulation of calcium signaling. Gene Set Enrichment Analysis (GSEA) confirmed the significant downregulation of these and other key Reactome pathways in non-type 2 asthma, such as those related to complement activation and Fc gamma receptor-dependent phagocytosis, indicating broad suppression of pathways crucial for allergic responses. Congruently, the serum levels of interleukin-4 (IL-4) and interleukin-9 (IL-9), cytokines vital for type 2 responses, were reduced, while interleukin-2 (IL-2) levels were positively associated with non-type 2 asthma. WGCNA identified a gene module positively correlated with total immunoglobulin E that was downregulated in non-type 2 asthma; this module included interleukin-4 messenger RNA and genes like\n                      <jats:italic>SLC7A8<\/jats:italic>\n                      and\n                      <jats:italic>SIGLEC8<\/jats:italic>\n                      , suggesting impaired type 2 innate lymphoid cell function. Furthermore, transcripts for immunoglobulin heavy chain variable (IGHV), kappa variable (IGKV), and lambda variable (IGLV) gene segments were markedly downregulated. Functional annotation (DAVID) of these segments revealed enrichment for terms related to immunoglobulin production and antigen binding; their reduced function likely contributes to decreased immunoglobulin E stability and altered antigen-binding affinity, underpinning negative sensitization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Non-type 2 asthma represents a distinct inflammatory endotype characterized by impaired type 2 helper cell differentiation, inhibited B-cell activation and immunoglobulin E class switching, and possibly skewed immunoglobulin variable gene usage linked to altered antibody specificity. These findings suggest a multi-faceted mechanism involving broad inhibition of key sensitization and immunoglobulin E production pathways, explaining the low serum immunoglobulin E levels and the absence of allergic sensitization in non-type 2 asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1711616","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:12:34Z","timestamp":1768205554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Low IgE and absence of sensitization in non-T2 asthma: a transcriptomic and cytokine study"],"prefix":"10.3389","volume":"16","author":[{"given":"Jyh-Hong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chieh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Luen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J Allergy Clin Immunology: In Practice"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(47)90204-0","article-title":"A working classification of asthma","volume":"3","author":"Rackemann","year":"1947","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.23504.x","article-title":"Allergic vs nonallergic asthma: what makes the difference","volume":"57","author":"Romanet-Manent","year":"2002","journal-title":"Allergy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1595","article-title":"Allergic and nonallergic forms of atopic diseases","volume":"112","author":"Novak","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-32259-4_6","article-title":"Phenotypes and endotypes in asthma","volume-title":"Precision Approaches to Heterogeneity in Asthma","author":"McIntyre","year":"2023"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40348-023-00159-1","article-title":"Childhood asthma phenotypes and endotypes: a glance into the mosaic","volume":"10","author":"Foppiano","year":"2023","journal-title":"Mol Cell Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"00309\u20132020","DOI":"10.1183\/23120541.00309-2020","article-title":"Identification and treatment of T2-low asthma in the era of biologics","volume":"7","author":"Kyriakopoulos","year":"2021","journal-title":"ERJ Open Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.11.006","article-title":"T2-\u201dLow\u201d Asthma: overview and management strategies","volume":"8","author":"Fitzpatrick","year":"2020","journal-title":"J Allergy Clin Immunol In practice"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-low and T2-high asthma phenotypes in real-life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"00125\u20132017","DOI":"10.1183\/23120541.00125-2017","article-title":"An algorithmic approach for the treatment of severe uncontrolled asthma","volume":"4","author":"Zervas","year":"2018","journal-title":"ERJ Open Res"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1002\/9780470694923.ch19","article-title":"Intrinsic asthma","author":"Virchow","year":"2000","journal-title":"Asthma Rhinitis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.09.006","article-title":"Asthma phenotypes: nonallergic (intrinsic) asthma","volume":"2","author":"Peters","year":"2014","journal-title":"J Allergy Clin Immunol In practice"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.04.020","article-title":"T2-low: what do we know?: Past, present, and future of biologic therapies in noneosinophilic asthma","volume":"129","author":"Niessen","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/all.14318","article-title":"Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.mam.2021.100995","article-title":"Cellular and molecular mechanisms of allergic asthma","volume":"85","author":"Koml\u00f3si","year":"2022","journal-title":"Mol Aspects Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/cells11040622","article-title":"Fc\u03f5RI: A master regulator of mast cell functions","volume":"11","author":"Nagata","year":"2022","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1839\u20131862","DOI":"10.1007\/s10753-024-02159-3","article-title":"Characterizing non-T2 asthma: key pathways and molecular implications indicative of attenuated th2 response","volume":"48","author":"Lee","year":"2024","journal-title":"Inflammation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.11.005","article-title":"GINA updated 2019: Landmark changes recommended for asthma management","volume":"124","author":"Hogan","year":"2020","journal-title":"Ann allergy Asthma Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.02.040","article-title":"Endotype of allergic asthma with airway obstruction in urban children","volume":"148","author":"Altman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"B26","article-title":"Systems biology applications to decipher mechanisms and novel biomarkers in CNS trauma","author":"Yu","year":"2015"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2215528119","DOI":"10.1073\/pnas.2215528119","article-title":"SLC7A8 is a key amino acids supplier for the metabolic programs that sustain homeostasis and activation of type 2 innate lymphoid cells","volume":"119","author":"Panda","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13681","article-title":"An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells","volume":"50","author":"Kerr","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/35037021","article-title":"Signalling through the high-affinity IgE receptor Fc\u03f5RI","volume":"402","author":"Turner","year":"1999","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41392-023-01344-4","article-title":"Pathogenesis of allergic diseases and implications for therapeutic interventions","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00045","article-title":"Editorial: BCR signaling and B cell activation","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064828","article-title":"Antigen presentation and T cell stimulation by dendritic cells","volume":"20","author":"Guermonprez","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402889","article-title":"Unlike in children with allergic asthma, igE transcripts from preschool children with atopic dermatitis display signs of superantigen-driven activation","volume":"196","author":"Kerzel","year":"2016","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"eaay4209","DOI":"10.1126\/sciimmunol.aay4209","article-title":"Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy","volume":"5","author":"Hoh","year":"2020","journal-title":"Sci Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2300826","DOI":"10.1183\/13993003.00826-2023","article-title":"Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies","volume":"64","author":"Liu","year":"2024","journal-title":"Eur Respir J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2020.10.002","article-title":"Mechanisms of non-type 2 asthma","volume":"66","author":"Hudey","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jaci.2015.06.038","article-title":"Type 2 innate lymphoid cells in induced sputum from children with severe asthma","volume":"137","author":"Nagakumar","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"PA861","DOI":"10.1183\/13993003.congress-2021.PA861","article-title":"Innate lymphocytes -ILC2- might be the drivers of T2-high nonatopic asthma in children","volume":"58","author":"Bonato","year":"","journal-title":"Eur Respir J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(00)90059-9","article-title":"Molecular mechanisms of IgE regulation","volume":"105","author":"Bacharier","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.aller.2018.02.003","article-title":"Features and roles of T helper 9 cells and interleukin 9 in immunological diseases","volume":"47","author":"Yazdani","year":"2019","journal-title":"Allergologia immunopathologia"},{"key":"B43","article-title":"Mechanism and regulation of IgE production in allergy","volume":"54","author":"Kurasawa","year":"1996","journal-title":"Nihon Rinsho"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.18.6880","article-title":"IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2","volume":"85","author":"Pene","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14080","article-title":"Increased nasal epithelial cell responsiveness to IL-17A in paediatric asthmatics with low blood neutrophil count, low traffic-related air pollution exposure and good asthma control","volume":"52","author":"McAlees","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.717962","article-title":"STAT3 and IL-6 contribute to corticosteroid resistance in an OVA and ozone-induced asthma model with neutrophil infiltration","volume":"8","author":"Xue","year":"2021","journal-title":"Front Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01033-0","article-title":"miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma","volume":"23","author":"Duan","year":"2023","journal-title":"Clin Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"14799","DOI":"10.1038\/s41598-023-41889-6","article-title":"Clinical characteristics and cytokine profiles of adult obese asthma with type2 inflammation","volume":"13","author":"To","year":"2023","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202205-0857ED","article-title":"Type 2 or non\u2013type 2 asthma exacerbations? That is the question","author":"Hudler","year":"2022","journal-title":"Am Thorac Society;"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4414\/SMW.2022.w30176","article-title":"New perspectives of biological therapy for severe asthma in adults and adolescents","volume":"152","author":"Chheang","year":"2022","journal-title":"Swiss Med Weekly"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0129OC","article-title":"Exacerbation profile and risk factors in a type-2\u2013low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes","volume":"206","author":"McDowell","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13550","article-title":"Cytokine levels in children and adults with wheezing and asthma show specific patterns of variability over time","volume":"204","author":"Weckmann","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/rr42","article-title":"Th2 cytokines and asthma \u2014 Interleukin-9 as a therapeutic target for asthma","volume":"2","author":"Zhou","year":"2001","journal-title":"Respir Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/biomedicines11041226","article-title":"T2-low asthma: A discussed but still orphan disease","volume":"11","author":"Peri","year":"2023","journal-title":"Biomedicines"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.786238","article-title":"Ruxolitinib ameliorates airway hyperresponsiveness and lung inflammation in a corticosteroid-resistant murine model of severe asthma","volume":"12","author":"Subramanian","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1711616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:12:37Z","timestamp":1768205557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1711616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2025.1711616"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1711616","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1711616"}}